Zealand Pharma Shares Fall 12% After Obesity Drug Trial Flags Side Effects

3-line summary

• Zealand Pharma shares fell 12% after its obesity drug trial flagged side effects, according to an Investing.com report.

This summary is our own processing of the source article; see the source link below for full context.